CreditReports.dk
HomeScreen companies

AVILEX PHARMA ApS Financials, key figures and credit report

CVR number: 34896828 Established 2012 Industry: 72 Scientific research and development
Company contact details
Ole Maaløes Vej 3, 2200 København N http://www.avilexpharma.com
Gross profit — FY 2025
EBIT -4 240.0 kDKK FY 2025 +11.7% vs 2024
Net debt 12 045.0 kDKK FY 2025 +65.6% vs 2024
Quick ratio 4.7 FY 2025 -0.7 vs 2024

Company information

Official name
AVILEX PHARMA ApS
Personnel
4 persons
Established
2012
Company form
Private limited company
Industry

Data sources and methodology

The information about AVILEX PHARMA ApS combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2025.

Open the 2025 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About AVILEX PHARMA ApS

AVILEX PHARMA ApS (CVR number: 3489682-8) is a company from KØBENHAVN. The company recorded a gross profit of 0 kDKK in 2025. The operating profit was -4240 kDKK, while net earnings were -4530 kDKK. The profitability of the company measured by Return on Assets (ROA) was -14.6 %, which can be considered poor and Return on Equity (ROE) was -22.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -37 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. AVILEX PHARMA ApS's liquidity measured by quick ratio was 4.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2021
2022
2023
2024
2025
Volume
Net sales45 479.00
Gross profit1 987.0045 479.00
EBIT-8 685.0034 858.00-6 034.00-4 803.00-4 240.00
Net earnings-7 316.0028 600.00-6 756.00-4 428.00-4 530.00
Shareholders equity total-28 051.004 917.00-1 839.00-6 267.00-10 797.00
Balance sheet total (assets)5 704.0031 596.0027 875.0021 559.0018 391.00
Net debt25 270.00-9 840.002 395.007 275.0012 045.00
Profitability
EBIT-%76.6 %
ROA-27.9 %118.9 %-19.4 %-10.1 %-14.6 %
ROE-97.0 %538.6 %-41.2 %-17.9 %-22.7 %
ROI-30.1 %129.0 %-21.2 %-10.7 %-14.8 %
Economic value added (EVA)-6 412.8527 303.14-5 937.14-5 754.62-4 359.22
Solvency
Equity ratio-83.1 %15.6 %-6.2 %-22.5 %-37.0 %
Gearing-92.2 %406.5 %-1 466.8 %- 436.3 %- 268.3 %
Relative net indebtedness %-6.9 %
Liquidity
Quick ratio2.113.23.65.44.7
Current ratio2.113.23.65.44.7
Cash and cash equivalents598.0029 827.0024 579.0020 067.0016 928.00
Capital use efficiency
Trade debtors turnover (days)
Net working capital %64.2 %

Variable visualization

ROA FY 2025
-14.6%
Rating 5/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2025
-37.0%
Rating 0/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of AVILEX PHARMA ApS before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Roles

Companies in the same industry

Page generated